Novo Nordisk (Denmark)

9.0k papers and 393.3k indexed citations i.

About

In recent decades, authors affiliated with Novo Nordisk (Denmark) have published 9.0k papers, which have received a total of 393.3k indexed citations. Scholars at this organization have produced 2.7k papers in Molecular Biology, 2.3k papers in Endocrinology, Diabetes and Metabolism and 1.2k papers in Surgery on the topics of Diabetes Treatment and Management (1.4k papers), Diabetes Management and Research (1.2k papers) and Pancreatic Islet Dysfunction and Regeneration (878 papers). Their work is cited by papers focused on Molecular Biology (116.9k citations), Endocrinology, Diabetes and Metabolism (103.9k citations) and Surgery (58.5k citations). Authors at Novo Nordisk (Denmark) collaborate with scholars in Denmark, United States and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Novo Nordisk (Denmark)'s most productive authors include Axel Brandenburg, Anders Krogh, C. J. Pethick, John Hertz, Lotte Bjerre Knudsen, A. M. Polyakov, H. Heiselberg, Ulla Hedner, Jens J. Holst and R. G. Palmer.

In The Last Decade

Fields of papers published by authors at Novo Nordisk (Denmark)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novo Nordisk (Denmark) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novo Nordisk (Denmark) at the time of their publication.

Countries citing scholars working at Novo Nordisk (Denmark)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novo Nordisk (Denmark). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novo Nordisk (Denmark) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novo Nordisk (Denmark) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025